Comparison Chart Capricor Therapeutics, Inc.
Stocks
CAPR
US14070B3096
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 4.210 USD | +0.48% |
|
+0.72% | -85.41% |
| 08-13 | Capricor Therapeutics, Inc., Q2 2026 Earnings Call, Aug 13, 2026 | |
| 07-31 | B. Riley Adjusts Capricor Therapeutics Price Target to $5 From $10, Maintains Neutral Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Bio Therapeutic Drugs | +0.48% | +0.72% | -85.41% | -49.28% | +4.21% | 244M |  | | |
- Stock Market
- Stocks
- CAPR Stock
- Charts Capricor Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
